1/ This scandal—misuse of the diagnosis 'schizophrenia' to hide the use of high-risk drugs in the elderly—is a crisis for psychiatry. We need to speak out—and demand the disciplining of doctors who misdiagnose to hide understaffing.
nytimes.com/2021/09/11/hea…
2/ That said, the scandal appears to arise from well-intentioned policy-making. You don't want to punish nursing homes that admit residents with mental illnesses or neurological disorders. Changing the metrics will only risk further unintended problems.
3/ Perhaps misdiagnosis should itself be a metric so that nursing homes that engage in it are downgraded and punished. (No institution should see a lot of schizophrenia that emerges in late life.) That move would require further expert oversight, to pre-COVID levels and beyond.
4/ Kudos to @nytimes for the exposé. Outstanding reporting—and please don't let the issue fade away.
Drugs and diagnoses are being misused, families are being mislead, corrupt nursing homes & professionals are flourishing, and people are dying—losing months & years of life.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Peter D. Kramer

Peter D. Kramer Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @PeterDKramer

13 Feb 19
@NYTObits writes of John Gunderson: "He was adamant over the years that psychiatric drugs did not help resolve #borderline symptoms." nyti.ms/2E6UmHv This statement is narrowly true. In lectures, he specified circumstances that warrant the use of a range of medications...
6 months ago, while arguing against widespread use of lamotrigine in #BPD, Gunderson wrote, "Clinical experience has shown that medications can help build an alliance, can relieve states of distress, and can sometimes be helpful for comorbid disorders." ajp.psychiatryonline.org/doi/10.1176/ap…
He spoke of instances when mood stabilizers, #SSRIs, and even antipsychotics might be of use. He spoke out against the overuse of medication but saw a role for judicious use in clinical management. ucdenver.edu/academics/coll…
Read 4 tweets
27 Jan 19
1/ Thread: New study forthcoming on whether #gene-testing can help guide #antidepressant selection for #depressed patients who have failed to respond to 1 or (on average) 3-4 trials of medication. bit.ly/2LQU75I I have been skeptical: mostly, scant added value…
2/ & I found the reporting of this study annoying. On the primary endpoint, improvement in average #depression rating scores, the gene-testing failed. Patients whose MDs chose new meds w/o help of gene tests did just as well—& yet news reports suggested that tests can help…
3/ That's because the gene testing led to a choice of new meds that led to significantly more remissions (patient no longer depressed) and responses (halving of symptom burden). In general, in drug trials, response/remission shows antidepressants to better effect…
Read 7 tweets
25 Jul 18
1/ Important study on #antidepressants & #heartdisease. 6 months of Rx for even minor depression in #cardiac patients offers protection against adverse events (heart attack, death, etc) seen for many (8+) years out. bit.ly/2LBZPuM @JAMA_current # of interesting points...
2/ The effects of meds on mood were the same as those in many other studies, 2-3 points difference on symptoms, NNT to remission between 5 & 6, effect size under .4 …& this difference, often dismissed as minor, was associated with marked benefits in terms of overall health...
3/ it looks as if treating about 10 patients early on prevents one heart attack, w & other benefits for heart (& overall) health. Benefits were larger in those whose mood disorder remitted & those who completed the trial. So: good news. Brief inexpensive Rx w lasting benefits...
Read 7 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(